Beta-blockers and renal continuum
Beta-blockers can be discussed as one of the approaches to limit chronic kidney disease progression, as well as to prevent cardiovascular complications in this patients. Therapeutic opportunities of beta-blockers should be explained by their effects on pathological sympathetic overactivation.G.P. Arutyunov, MD, PhD, Prof; L.G. Oganezova, MD
Keywords
beta-blockers
arterial hypertension
cardio-renal syndrome
chronic renal failure
sympathetic overactivation
Similar Articles
